Stock Analiz

Marex Group Ltd MRX

Investment Bankers/Brokers/Service · IPO 2024 · data as of November 13, 2026

$70.72Market cap $5.2B
Open the interactive analysis →

Marex Group Ltd (MRX) is a financial company listed in the US with a market value of about $5.2B. In the twelve months to September 30, 2026 it had revenue of $4.8B and net income of $470M, a net margin of 9.9%.

Its overall Stock Analiz score is 2.6 out of 5 (average). The strongest part is future growth (5/5); the weakest is track record (1/5).

Key numbers: a P/E of 11.7, a price to free cash flow of 8.0. A discounted cash flow model with moderate assumptions puts its intrinsic value about 41% above the current price.

Score: 2.6 / 5

Value4/5
Future growth5/5
Track record1/5
Financial health1/5
Shareholder returns2/5

Checks passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • Profit margin improving
  • 3-year free cash flow growth above 10% a year

Checks not passed

  • PEG below 1.5
  • 5-year EPS growth above 10% a year
  • 5-year revenue growth above 8% a year
  • 5-year average ROIC above 12%
  • Profitable 5 years in a row
  • More cash than debt, or low debt to equity
  • Interest covered more than 5 times
  • Debt below 3 years of free cash flow

Valuation

P/E (TTM)11.7
Forward P/E10.2
P/FCF8.0
P/S1.1
P/B2.7
EV/EBITDA—
PEG—
Dividend yield0.87%
FCF yield12.5%
Shareholder yield1.7%
Intrinsic value vs. price+41%

Growth and quality

Revenue growth (1 yr)26.9%
Revenue growth (5 yrs, per year)—
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)43.4%
Net margin (5-yr avg.)12.6%
ROIC (5-yr avg.)—
Profitable years (of last 10)4
Years paying a dividend4

Financials, last 4 years

Fiscal yearTTM2025202420232022
Revenue$4.8B$2.0B$1.6B$1.2B$711M
Net income$470M$294M$205M$128M$92M
Free cash flow—$654M$1.2B$726M$222M
EPS (diluted)$6.05$3.96$2.76$1.73$1.24
Net margin9.9%14.5%12.8%10.3%12.9%
ROIC—————

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

What analysts expect

The average 12-month price target from 8 analysts is $82.88, 17% above the current price; targets range from $36.00 to $101.00; the consensus rating is “Buy”; expected EPS is $6.27 for the fiscal year ending December 31, 2026.

Frequently asked questions

What is Marex Group’s P/E ratio?

About 11.7, based on the last twelve months of diluted earnings per share (forward P/E about 10.2).

Is Marex Group stock undervalued?

Our DCF model with moderate assumptions puts its intrinsic value about 41% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.

Does Marex Group pay a dividend?

Yes. The dividend yield is about 0.87%, and it has paid dividends for 4 years in our data.

Is Marex Group a good stock to buy?

We do not give buy or sell advice. Marex Group scores 2.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.